SP has published a book, The Circadian Code, focusing on the concept of TRE. iMotions A/S is a collaborator on the project and gives advice for the use and analysis of biometric methods in the study design phase. HP is a coinvestigator on the project which is part of her Industrial PhD project in collaboration with iMotions A/S, where HP is employed. The investigators employed at Steno Diabetes Center Copenhagen will not benefit economically from conducting the study. The Novo Nordisk Foundation will not have an influence on the study design, data collection, analysis, interpretation of data, the writing of the study report or any publication and the decision to submit the paper for publication. The Novo Nordisk Foundation has no economic interests in the study. Steno Diabetes Center Copenhagen is partly funded by the Novo Nordisk Foundation through unrestricted grants. Published by BMJ.Ĭompeting interests: Steno Diabetes Center Copenhagen is a hospital providing health services for the public healthcare system. Results from the study will address whether TRE is effective and feasible in improving health outcomes in individuals at risk of lifestyle-related diseases and can potentially inform the design of feasible health recommendations.ĭiabetes & endocrinology nutrition & dietetics. The study will be conducted in accordance with the Declaration of Helsinki. The study has been approved by the Ethics Committee of the Capital Region of Denmark (H-18059188) and the Danish Data Protection Agency. After the 3-month intervention, a 3-month follow-up period and subsequent testing are scheduled to assess maintenance and longer-term effects.
Motivation and feasibility will be examined based on interviews at baseline and after 3 months. Secondary outcomes include changes in body composition measures of glucose metabolism including glycaemic variability, hormones and metabolites subjective and metabolic markers of appetite, food preferences and reward dietary intake physical activity, sleep, chronotype gastric emptying, gastrointestinal transit time and motility respiratory and glycolytic capacities the plasma proteome and metabolome blood pressure, resting heart rate and heart rate variability and resting energy expenditure and substrate oxidation. The primary outcome is change in body weight after 3 months of intervention.
Testing is scheduled at baseline and after 6 weeks (mid-intervention), 3 months (post-intervention) and 6 months (follow-up). 100 women and men with (1) overweight (body mass index (BMI)≥25 kg/m 2) and prediabetes (glycated haemoglobin 39-47 mmol/mol) or (2) obesity (BMI≥30 kg/m 2) will be randomised to a control group (habitual living) or TRE (self-selected 10-hours eating window within the period from 06:00 to 20:00 in a 1:1 ratio. The REStricted Eating Time (RESET) study is a randomised controlled parallel-group open-label trial. The aim of this study is to investigate the effects of time-restricted eating (TRE) on change in body weight and describe changes in behaviour and metabolism in individuals at high risk of type 2 diabetes. 12 School of Psychology, University of Leeds, Leeds, UK.11 Mech-Sense, Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark.10 Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.9 Salk Institute for Biological Studies, La Jolla, California, USA.8 National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark.7 Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.6 Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.5 Department of Clinical Biochemistry, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.4 Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.3 iMotions A/S, Frederiksberg, Denmark.1 Steno Diabetes Center Copenhagen, Gentofte, Denmark 2 Steno Diabetes Center Copenhagen, Gentofte, Denmark.
0 kommentar(er)
